Showing items 1 - 4 of 4

Your selections:

Depot buprenorphine as an opioid agonist therapy in New South Wales correctional centres: a costing model

- Ling, R., White, B., Roberts, J., Cretikos, M., Howard, M. V., Haber, P. S., Lintzeris, N., Reeves, P., Dunlop, A. J., Searles, A.

Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: a survey of preferences, attitudes and beliefs among patients willing to consider participation

- Luckett, T., Phillips, J., Currow, D., Chye, R., Lovell, M., McGregor, I., Agar, M., Lintzeris, N., Allsop, D., Lee, J., Solowij, N., Martin, J., Lam, L., Aggarwal, R., McCaffrey, N.

Cannabinoid replacement therapy (CRT): Nabiximols (Sativex) as a novel treatment for cannabis withdrawal

- Allsop, D.J., Lintzeris, N., Copeland, J., Dunlop, A., McGregor, I.S.

A randomised controlled trial of sublingual buprenorphine-naloxone film versus tablets in the management of opioid dependence

- Lintzeris, N., Leung, S. Y., Ali, R., Dunlop, A. J., Larance, B., White, N., Rivas, G. R., Holland, R. M., Degenhardt, L., Muhleisen, P., Hurley, M.

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit